FDA approves Moderna’s new lower-dose COVID-19 vaccine

What you need to know about Moderna's new COVID vaccine, just approved by the FDA

Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and those between 12 and 64 with at least one underlying risk factor as defined by the Centers for Disease Control and Prevention. Moderna’s COVID shot had previously been approved for everyone 12 and older. The narrower approval follows the FDA announcing it w…

Moderna rises after FDA grants limited approval for next-gen Covid vaccine

Moderna CEO Stéphane Bancel said on Thursday narrowing the eligibility while focusing on high-risk individuals could actually lead to more immunizations....

Moderna wins narrower US approval for new COVID vaccine

Moderna Inc. gained U.S. approval for a new COVID vaccine for a narrower group of people, in the latest sign that regulators are restricting access to immunizations under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr.

Marjorie Taylor Greene fumes over vaccine approval: 'Not MAHA at all'

The FDA has approved Moderna's new lower-dose COVID-19 vaccine.

FDA approves Moderna's new COVID-19 vaccine

ABC News reports that the U.S. Food and Drug Administration (FDA) has approved a new, lower-dose version of Moderna’s COVID-19 vaccine. This updated vaccine is designed to provide continued protection against current variants of the virus while potentially reducing side effects due to its lower dosage. The approval comes as part of ongoing efforts to […]

FDA approves Moderna's new lower-dose Covid-19 vaccine

The U.S. approved a new Covid-19 vaccine made by Moderna but with limits on who can use it — not a replacement for its existing shot, but a second option.